Kevin Judice is CEO of DICE Therapeutics, Inc.. Currently has a direct ownership of 0 shares of DICE, which is worth approximately $0. The most recent transaction as insider was on Aug 09, 2023, when has been sold 799,685 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Kevin Judice Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 09 2023
SELL
Sale (or disposition) back to the issuer
-
799,685 Reduced 100.0%
0 Common Stock
May 03 2023
SELL
Open market or private sale
$499,977 $36.5 p/Share
13,698 Reduced 1.68%
799,685 Common Stock
KJ

Kevin Judice

CEO
South San Francisco, CA

Track Institutional and Insider Activities on DICE

Follow DICE Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DICE shares.

Notify only if

Insider Trading

Get notified when an Dice Therapeutics, Inc. insider buys or sells DICE shares.

Notify only if

News

Receive news related to DICE Therapeutics, Inc.

Track Activities on DICE